B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PLD2

MOLECULAR TARGET

phospholipase D2

UniProt: O14939NCBI Gene: 53383 compounds

PLD2 (phospholipase D2) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PLD2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1raloxifene4.77117
2halopemide1.956
3Oleic Acid0.691

About PLD2 as a Drug Target

PLD2 (phospholipase D2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented PLD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PLD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.